Get the Stockscreener App
31.13
0.86%
-0.27
After Hours:
31.13
Immunocore Holdings Plc Adr stock is traded at $31.13, with a volume of 121.58K.
It is down -0.86% in the last 24 hours and down -13.24% over the past month.
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.
See More
Previous Close:
$31.40
Open:
$31.15
24h Volume:
121.58K
Relative Volume:
0.29
Market Cap:
$1.54B
Revenue:
$345.60M
Net Income/Loss:
$-79.01M
P/E Ratio:
-24.28
EPS:
-1.2822
Net Cash Flow:
$-18.62M
1W Performance:
+1.07%
1M Performance:
-13.24%
6M Performance:
-52.11%
1Y Performance:
-40.02%
1-Day Range:
$30.43
$31.53
1-Week Range:
$29.76
$31.53
52-Week Range:
$29.76
$76.98
Immunocore Holdings Plc Adr Stock (IMCR) Company Profile
Name
Immunocore Holdings Plc Adr
Sector
Industry
Phone
01235 5430281
Address
90 PARK DRIVE, OXFORDSHIRE
Immunocore Holdings Plc Adr Stock (IMCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-23 | Resumed | JP Morgan | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-31-23 | Initiated | Robert W. Baird | Outperform |
| Sep-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Sep-13-23 | Initiated | Needham | Buy |
| Aug-16-23 | Initiated | CapitalOne | Overweight |
| Jul-17-23 | Initiated | Canaccord Genuity | Hold |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-30-23 | Initiated | Guggenheim | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Dec-16-22 | Upgrade | Goldman | Neutral → Buy |
| Nov-30-22 | Initiated | Barclays | Overweight |
| Sep-09-22 | Initiated | Morgan Stanley | Overweight |
| Sep-08-22 | Initiated | Ladenburg Thalmann | Buy |
| Aug-08-22 | Initiated | Cowen | Outperform |
| Aug-02-22 | Initiated | BTIG Research | Buy |
| Feb-08-22 | Initiated | H.C. Wainwright | Buy |
| Oct-20-21 | Initiated | Oppenheimer | Outperform |
| Mar-02-21 | Initiated | Goldman | Neutral |
| Mar-02-21 | Initiated | JP Morgan | Overweight |
| Mar-02-21 | Initiated | Jefferies | Buy |
View All
Immunocore Holdings Plc Adr Stock (IMCR) Latest News
Financial Fitness Check: Examining Immunocore Holdings plc ADR (IMCR)’s Key Ratios - The Dwinnex
Immunocore stock hits 52-week low at $32.07 amid market challenges - Investing.com
TD Cowen maintains Buy rating on Immunocore shares on ovarian cancer drug data - Investing.com India
Quarterly Metrics: Quick and Current Ratios for Immunocore Holdings plc ADR (IMCR) - The Dwinnex
Immunocore Holdings plc ADR (IMCR) is looking forward to a strong quarter - SETE News
Immunocore stock hits 52-week low at $32.84 amid market challenges - Investing.com
Immunocore stock hits 52-week low at $32.84 amid market challenges - Investing.com India
Ratios Revealed: Decoding Immunocore Holdings plc ADR (IMCR)’s Financial Health - The Dwinnex
Have you been able to find a good deal on Immunocore Holdings plc ADR’s shares? - US Post News
Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds - Yahoo Finance UK
The growth track for Immunocore Holdings plc ADR (IMCR) has changed recently - SETE News
The Potential Rise in the Price of Sun Communities, Inc. (SUI) following insiders activity - Knox Daily
Insider Sale Alert: Terns Pharmaceuticals Inc [TERN] – Is it Time to sell? - Knox Daily
Immunocore Holdings plc ADR (IMCR) may enjoy gains as insiders got busy in the recent days - Knox Daily
Monitoring Brookline Bancorp, Inc. (BRKL) after recent insider movements - Knox Daily
Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds - MSN
Immunocore Holdings plc ADR [IMCR] Shares Fall -4.18% on Thursday - Knox Daily
Financial Health Report: Immunocore Holdings plc ADR (IMCR)’s Ratios Tell a Tale - The Dwinnex
Immunocore Holdings plc (IMCR): Top ADR Stock According to Hedge Funds - Insider Monkey
Insider Sale: President Brian Hole Sells Shares of Willis Lease Finance Corp (WLFC) - Yahoo Finance UK
IMCR’s 52-Week Rollercoaster: From $33.04 to $76.98 – What’s Next for Investors? - The InvestChronicle
Immunocore CFO to depart, company seeks replacement - Investing.com
IMCR’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Immunocore Holdings plc ADR [IMCR] Insider Activity: An Update for Investors - Knox Daily
Top 10 ADR Stocks To Buy According to Hedge Funds - Insider Monkey
Ratio Examination: Immunocore Holdings plc ADR (IMCR)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Examining the Potential Price Growth of Immunocore Holdings plc ADR (IMCR) - Knox Daily
Cancer Immunotherapy Market Size Expected to Touch USD 530.2 Billion by 2034, With 14.2% CAGR Growth: Prophecy Market Insights - GlobeNewswire Inc.
Potential Price Increase for Immunocore Holdings plc ADR (IMCR) After Recent Insider Activity - Knox Daily
Mizuho backs Outperform rating for Immunocore stock despite PT cut - Investing.com
Earnings call: Immunocore reports robust growth for KIMMTRAK in Q2 - Investing.com India
Earnings call: Immunocore reports robust growth for KIMMTRAK in Q2 - Investing.com
It would be worthwhile to take a closer look at Immunocore Holdings plc ADR (IMCR) - US Post News
Insider Selling Buzz: Immunocore Holdings plc ADR [IMCR] CHIEF HR OFFICER St Leger Tina Amber sold 4,375 shares of the company – Knox Daily - Knox Daily
An Analysis of Immunocore Holdings plc ADR (IMCR)’s Potential Price Growth - Knox Daily
Trading Day Review: Immunocore Holdings plc ADR (IMCR) Loses Momentum, Closing at 38.87 - The Dwinnex
Prepare Yourself for Liftoff: Immunocore Holdings plc ADR (IMCR) - SETE News
Should investors be concerned about Immunocore Holdings plc ADR (IMCR)? - US Post News
Keeping an Eye on Immunocore Holdings plc ADR (IMCR) After Insider Trading Activity - Knox Daily
Singtel backs amalgamation of Intouch and GULF to simplify AIS’s holding structure - Yahoo Finance
BTO June 2024: Alternative Resale Flats to Consider in the Same Estates - Yahoo Finance
Advanced Melanoma Clinical Trial Pipeline Analysis - GlobeNewswire Inc.
A Look at Immunocore Holdings plc ADR (IMCR) Shares in the Recent Past Indicates Growth - SETE News
Immunocore Holdings plc ADR (IMCR) Becoming More Attractive for Investors - Knox Daily
Immunocore Holdings plc ADR (IMCR) is looking forward to a strong quarter – Sete News - SETE News
Immunocore Holdings plc ADR [IMCR] Revenue clocked in at $266.18 million, down -47.28% YTD: What's Next? – The ... - The DBT News
why Cenovus Energy Inc [CVE] is a Good Choice for Investors After New Price Target of $24.59 – The DBT News - The DBT News
Bitdeer Technologies Holding Co [BTDR] gain 17.75% so far this year. What now? - The DBT News
Market cap of Akoustis Technologies Inc [AKTS] reaches 12.67M – now what? - The DBT News
Insider Sale Alert: Immunocore Holdings plc ADR [IMCR] – Is it Time to sell? – Knox Daily - Knox Daily
Immunocore Holdings plc ADR: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle
Immunocore Holdings Plc Adr Stock (IMCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):